Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment.
about
The role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sicknessDiscovery of Infection Associated Metabolic Markers in Human African TrypanosomiasisA combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patientsImmunobiology of African trypanosomes: need of alternative interventionsCardiac involvement with parasitic infections.Unravelling human trypanotolerance: IL8 is associated with infection control whereas IL10 and TNFα are associated with subsequent disease developmentStage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambienseDiscovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasisInterleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness.Human African trypanosomiasis of the CNS: current issues and challengesTreatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sicknessHuman African trypanosomiasis: clinical presentation and immune response.Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma responseHuman host determinants influencing the outcome of Trypanosoma brucei gambiense infections.Severity of human african trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile.Trypanosomiasis and the brain.The relationship of endotoxaemia to peripheral and central nervous system inflammatory responses in Human African Trypanosomiasis.Emerging trends in the diagnosis of human African Trypanosomiasis.A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence.Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients.Comparison of cytokine plasma levels in human African trypanosomiasis.Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis.Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages.IL-6 is upregulated in late-stage disease in monkeys experimentally infected with Trypanosoma brucei rhodesiense.A polymorphism in the haptoglobin, haptoglobin related protein locus is associated with risk of human sleeping sickness within Cameroonian populations.An insight of sleep disorders in Africa.
P2860
Q26775041-E447379F-DFA0-45A0-8156-19CE732AAF6BQ28550504-0D2C4BE6-6108-46BD-A70C-44680872799FQ33474338-62C6A4D3-5699-41F8-8C01-D834B6BFADF0Q33680317-EBD70490-2980-429F-BD43-06E8506E4ECFQ33825602-3A67A30F-31A8-4307-AD59-13E4B3FC918FQ34466454-13023B29-3AF4-4623-8D7C-43750D301366Q34474577-32E56F6A-E591-4B21-BDF0-5663D5B9D2B5Q34796896-72C9404E-F804-4896-8D1F-8CE1D642CE12Q35006575-FC2399E6-ACA6-407A-B5DD-78A79E165686Q35668603-3A81876D-6C08-4A2B-9B2E-42A5C17631CBQ35668843-8440C180-1539-4000-8A9A-A8435F765C24Q35946968-C49897F7-3570-4BFB-8027-8AF36952759DQ36072554-1D12FC7A-54B5-4EE6-ACE8-D2032752420AQ36152727-9143FF42-D70D-4794-B214-C31F3F4FB6E3Q36189949-9A731CD1-2F68-4B6B-B4EE-D0A84261B379Q37624109-147B328B-1058-4C54-B7D0-C4E495A1B698Q37661154-CFE4311C-DE33-4FB3-93EE-34078A17556BQ37724084-B2FA1DF5-383F-4F7E-AA01-5ADFB4482204Q37728108-A39B8CF5-CE30-47E5-B789-030A453C4DABQ37776021-34BDC31C-F479-407E-BF7E-F12149908C2AQ38880051-A1783890-F3ED-4E94-9FEE-F757534D6434Q38954875-A0ADBCDE-102A-4530-AD3E-EE9076794B28Q40595918-0C927D4D-6B2A-40F1-B5AD-FF0826128785Q40622179-2D58ECED-C73E-435B-B721-B80BACBF5C80Q41901235-44DF21AA-E836-441E-8275-30A058A196B7Q43923950-04F04B69-9098-4AF3-861A-09414D91F911Q50072418-E43BF29C-7FD5-4B56-A2D1-9CF78D6AF42C
P2860
Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Interleukin (IL)-6, IL-8 and I ...... ts before and after treatment.
@en
Interleukin (IL)-6, IL-8 and I ...... ts before and after treatment.
@nl
type
label
Interleukin (IL)-6, IL-8 and I ...... ts before and after treatment.
@en
Interleukin (IL)-6, IL-8 and I ...... ts before and after treatment.
@nl
prefLabel
Interleukin (IL)-6, IL-8 and I ...... ts before and after treatment.
@en
Interleukin (IL)-6, IL-8 and I ...... ts before and after treatment.
@nl
P2093
P921
P1476
Interleukin (IL)-6, IL-8 and I ...... nts before and after treatment
@en
P2093
P304
P356
10.1016/S0035-9203(02)90115-X
P577
2002-05-01T00:00:00Z